Medicare Part B Premium Reduction In 2023 Has Reserves Built In If Lecanemab Launches

But premiums in future years made need to keep pace with accelerating Medicare spending on Alzheimer’s drugs.

Beneficiaries Could Share Coverage Burden For Alzheimer's Drugs Later • Source: Shutterstock

More from Market Access

More from Pink Sheet